However, about 7% discontinued treatment due to side effects
Find the right provider for your needs select your state to find expert care near you.
HIPAA Compliant Perfect Pomegranates HIPAA privacy notice lives on its own dedicated page in the footer
SECURE CHECKOUT Encrypted payments & private order details RESEARCH-GRADE QUALITY 99% HPLC purity across the catalog THIRD-PARTY TESTED Independently verified by Janoshik Analytical DISCREET SHIPPING Sealed, unbranded, tracked worldwide Global Fulfillment Network Fast, secure, and discreet fulfillment through our Canada and Philippines distribution network
By target indication, the obesity/chronic weight management segment is expected to expand at the fastest CAGR from 2026 to 2035
P-LLY Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about retatrutide as a potential treatment for adults with obesity or overweight and knee osteoarthritis, potential efficacy and tolerability of retatrutide, and the timeline for future readouts, presentations, and other milestones relating to retatrutide and its clinical trials and reflects Lilly's current beliefs and expectations
)
